Iwicki Mark T
Insider CIK 1415537 · KALA Chief Executive Officer, Director, 10% owner · PULM Director · AIMT Director · MRUS Director · QTTB Director · AKRO Director · IKT Chief Executive Officer, Director · AVTE Director · THRD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-07-21 | 10,826 | — | $0 | 10,826 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 9,810 | — | $0 | 9,810 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2026-01-05 | 2026-01-07 | 4,982,706 | — | $0 | 4,982,706 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 6,120 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 4,983 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 5,650 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,631 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,500 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 16,604 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 14,414 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,844 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 13,193 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | U Tender | 2025-12-12 | 2025-12-12 | 73,576 | $97.00 | $7.14M | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 76,227 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 11,493 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,587 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-10-23 | 2025-10-27 | 53,521 | — | $0 | 53,521 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-10-23 | 2025-10-24 | 154,894 | $0.81 | $125.5K | 103,540 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | J Other deriv | 2025-08-11 | 2025-08-14 | 83,296 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | J Other | 2025-08-11 | 2025-08-14 | 128,631 | — | $0 | 0 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-24 | 2025-06-26 | 13,227 | $4.01 | $53.0K | 258,433 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-06-15 | 2025-06-17 | 5,450 | — | $0 | 5,450 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2025-06-15 | 2025-06-17 | 2,450 | — | $0 | 271,660 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-03 | 2025-06-04 | 10,866 | $3.74 | $40.6K | 269,210 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 10,866 | $3.74 | $40.6K | 269,210 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2025-05-22 | 2025-05-27 | 13,193 | — | $0 | 13,193 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 25,534 | — | $0 | 25,534 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 37,222 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 37,222 | — | $0 | 37,222 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 7,615 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 7,615 | — | $0 | 7,615 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 25,534 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-21 | 2025-07-02 | 602,346 | — | $0 | 602,346 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-21 | 2025-02-25 | 602,346 | — | $0 | 602,346 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-17 | 2025-02-19 | 1,794,291 | — | $0 | 1,794,291 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-14 | 2025-02-19 | 4,373,857 | — | $0 | 4,373,857 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-01-06 | 2025-01-07 | 99,500 | — | $0 | 99,500 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2025-01-06 | 2025-01-07 | 22,100 | — | $0 | 285,855 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 5,779 | $7.63 | $44.1K | 280,076 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-06-26 | 2024-06-27 | 15,168 | $4.75 | $72.0K | 263,755 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-06-08 | 2024-06-11 | 26,000 | — | $0 | 26,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-05-31 | 2024-06-03 | 7,392 | $6.09 | $45.0K | 278,923 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2024-05-07 | 2024-05-09 | 8,844 | — | $0 | 8,844 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 25,534 | — | $0 | 25,534 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 64,500 | — | $0 | 64,500 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-01-04 | 2024-01-05 | 4,539 | $6.73 | $30.5K | 286,315 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2024-01-04 | 2024-01-05 | 14,300 | — | $0 | 290,854 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 211,831 | — | $0 | 211,831 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-06-22 | 2023-06-23 | 158,873 | — | $0 | 276,554 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2023-06-08 | 2023-06-12 | 14,414 | — | $0 | 14,414 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 9,199 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 15,499 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 6,059 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 5,449 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 7,299 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,268 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 7,576 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 12,195 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 1,572 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 4,599 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-05-31 | 2023-06-02 | 71,715 | — | $0 | 117,681 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2023-04-14 | 2023-04-17 | 36,944 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2023-04-14 | 2023-04-17 | 36,632 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2023-04-14 | 2023-04-17 | 36,944 | $6.57 | $242.7K | 36,944 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2023-04-14 | 2023-04-17 | 36,632 | $7.97 | $292.0K | 73,576 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-03-14 | 2023-03-15 | 1,512 | — | $0 | 1,512 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 35,413 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 35,413 | — | $0 | 35,413 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-01-04 | 2023-01-06 | 41,700 | — | $0 | 46,164 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2023-01-04 | 2023-01-06 | 198 | $28.54 | $5.7K | 45,966 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-10-26 | 2022-10-28 | 561 | $6.52 | $3.7K | 4,464 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-06-27 | 2022-06-29 | 7,975 | $0.37 | $3.0K | 251,183 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2022-06-21 | 2022-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2022-05-31 | 2022-06-02 | 16,604 | — | $0 | 16,604 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 9,518 | $1.30 | $12.4K | 259,158 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 775,000 | — | $0 | 775,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-10-26 | 2021-10-28 | 27,598 | $1.80 | $49.7K | 268,676 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-06-29 | 2021-07-01 | 42,200 | — | $0 | 42,200 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-06-28 | 2021-06-29 | 7,586 | $5.77 | $43.8K | 296,274 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 13,000 | — | $0 | 13,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2021-05-28 | 2021-06-02 | 6,120 | — | $0 | 6,120 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-04-02 | 2021-07-01 | 76,747 | — | $0 | 76,747 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-04-02 | 2021-07-01 | 39,550 | — | $0 | 39,550 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2021-01-28 | 2021-02-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2021-01-04 | 2021-01-05 | 303,000 | — | $0 | 303,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2021-01-04 | 2021-01-05 | 76,000 | — | $0 | 303,860 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-10-26 | 2020-10-28 | 178,300 | — | $0 | 227,860 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 87,368 | $28.21 | $2.46M | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 52,421 | $31.48 | $1.65M | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 19,755 | $19.10 | $377.3K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 17,500 | $16.24 | $284.2K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 7,500 | $1.71 | $12.8K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 11,432 | $14.60 | $166.9K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 15,398 | $17.39 | $267.8K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer | 2020-10-13 | 2020-10-14 | 7,840 | $34.50 | $270.5K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | U Tender | 2020-10-10 | 2020-10-14 | 39,567 | $34.50 | $1.37M | 0 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2020-06-30 | 2020-07-02 | 8,631 | — | $0 | 8,631 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-06-25 | 2020-06-29 | 49,560 | — | $0 | 49,560 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-06-01 | 2020-06-02 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2020-05-27 | 2020-05-29 | 15,398 | — | $0 | 15,398 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2020-05-27 | 2020-05-29 | 7,840 | — | $0 | 47,407 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-04-02 | 2020-04-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 365,000 | — | $0 | 365,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2019-05-23 | 2019-05-28 | 11,432 | — | $0 | 11,432 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2019-05-23 | 2019-05-28 | 6,442 | — | $0 | 39,567 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2019-05-16 | 2019-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-01-02 | 2019-01-04 | 460,000 | — | $0 | 460,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2018-06-05 | 2018-06-06 | 155,000 | — | $0 | 155,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2018-05-23 | 2018-05-24 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2018-05-23 | 2018-05-24 | 3,750 | — | $0 | 33,125 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 307,000 | — | $0 | 307,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 307,000 | — | $0 | 307,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy | 2018-04-03 | 2018-04-05 | 307,000 | — | $0 | 307,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2018-02-26 | 2018-02-26 | 9,375 | $32.00 | $300.0K | 29,375 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-02-07 | 2018-02-09 | 230,000 | — | $0 | 230,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-07-19 | 2017-07-21 | 78,632 | — | $0 | 78,632 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2017-05-25 | 2017-05-30 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2017-03-20 | 2017-03-22 | 4,400 | — | $0 | 4,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2016-05-25 | 2016-05-27 | 19,755 | — | $0 | 19,755 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-12-08 | 2015-12-09 | 73,481 | — | $0 | 73,481 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2015-08-11 | 2015-08-11 | 20,000 | $16.00 | $320.0K | 20,000 | SEC↗ |